Lv2
120 积分 2023-10-08 加入
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
14天前
已关闭
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and MultipleAscending Dose Study of AMG 133 in Subjects with Obesity
16天前
已关闭
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression
1个月前
已完结
siRNAs—A New Class of Medicines
1个月前
已完结
Analysis of Fixed-Dose Combination Products Approved by the US Food and Drug Administration, 2010–2015: Implications for Designing a Regulatory Shortcut to New Drug Application
1个月前
已完结
Inflammasomes in neurological disorders — mechanisms and therapeutic potential
2个月前
已完结
Inflammasomes in the CNS
2个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
2个月前
已完结
New epilepsy therapies in development
2个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
3个月前
已完结
皖公网安备34019202002308
